A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years Read more about A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to
Determining the Causes of Genital Discharge and Establishment of Sub-regional Reference Laboratory to support Gonococcal Antimicrobial Surveillance Programme in Africa Read more about Determining the Causes of Genital Discharge and Establishment of Sub-regional Reference Laboratory to support Gonococcal Antimicrobial Surveillance Programme in Africa
An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya Read more about An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya
